<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01615003</url>
  </required_header>
  <id_info>
    <org_study_id>NNSF81173116</org_study_id>
    <nct_id>NCT01615003</nct_id>
  </id_info>
  <brief_title>The Study of MicroRNA Genomics of Blood Stasis Syndrome and of Coronary Heart Disease</brief_title>
  <official_title>The Analysis of Blood Stasis Syndromeand of Coronary Heart Disease Related MicroRNA Genomics and Target Gene Regulatory Networks</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guang'anmen Hospital of China Academy of Chinese Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guang'anmen Hospital of China Academy of Chinese Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, typical cases of blood stasis syndrome of coronary heart disease are selected,
      by using microRNA chip, cDNA microarray and other bioinformatics technologies to filter and
      verify related miRNA and its target gene of Coronary Heart disease. Meanwhile, intervene by
      Xuesaitong soft capsules to investigate related miRNA and its target gene of Coronary Heart
      disease.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2012</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the change of Cycle threshold of relational microRNA in coronary artery disease with unstable angina</measure>
    <time_frame>1 month</time_frame>
    <description>The change of Cycle threshold of relational microRNA in coronary artery disease with unstable angina by real RT-PCR.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Coronary Heart Disease</condition>
  <condition>Unstable Angina</condition>
  <condition>Blood Stasis Syndrome</condition>
  <arm_group>
    <arm_group_label>Xuesaitong soft capsule group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who confirmed by coronary angiography and diagnosed blood stasis syndrome of coronary heart disease are given conventional Western medicine treatment and Xuesaitong soft capsule.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients who confirmed by coronary angiography and diagnosed blood stasis syndrome of coronary heart disease are given conventional Western medicine treatment and placebo.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Xuesaitong soft capsule</intervention_name>
    <description>Xuesaitong soft capsule, soft capsule, Ingredients:PNS, Specification:0.33 per bag, once take two pills and twice a day during a month.</description>
    <arm_group_label>Xuesaitong soft capsule group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Xuesaitong soft capsule Placebo</intervention_name>
    <description>Xuesaitong soft capsule Placebo, soft capsule, once take two pills and twice a day during a month.</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of coronary angiography unstable angina

          -  Clinical diagnosis of unstable angina

          -  Age of 30 to 75 years old

          -  Not use thrombolysis, dilate coronary drugs within two weeks

          -  Tongue dark

          -  Sign the consent

        Exclusion Criteria:

          -  Severe valvular heart disease

          -  Insulin-dependent diabetes

          -  mental disease

          -  Combined with severe liver, kidney, hematopoietic system disorder

          -  Patients with malignant tumors

          -  Pregnancy or breast-feeding women

          -  Recent history of trauma

          -  Drug allergy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fei Teng, master</last_name>
    <phone>13581985462</phone>
    <email>echo-teng@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Guang'an men Hispital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fei Teng, master</last_name>
      <phone>13581985462</phone>
      <email>echo-teng@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Gui Yu, master</last_name>
      <phone>13488835663</phone>
    </contact_backup>
    <investigator>
      <last_name>Jie Wang, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 28, 2012</study_first_submitted>
  <study_first_submitted_qc>June 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 8, 2012</study_first_posted>
  <last_update_submitted>January 12, 2014</last_update_submitted>
  <last_update_submitted_qc>January 12, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>MicroRNA</keyword>
  <keyword>coronary heart disease</keyword>
  <keyword>unstable angina</keyword>
  <keyword>blood stasis syndrome</keyword>
  <keyword>Xuesaitong soft capsule</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Angina, Unstable</mesh_term>
    <mesh_term>Blind Loop Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

